Company Fact Sheet

Overview: Provista Life Sciences is a biotechnology diagnostics development and commercialization organization focused on providing the scientific and operating management resources to advance rapidly the development and introduction of cutting-edge diagnostic technologies.

Specifically, the organization offers healthcare professionals and patients innovative tests to aid in the early detection of cancers and Alzheimer's diseases. Provista Life Sciences' breakthrough testing technologies are changing the healthcare diagnostics market by helping people live longer, healthier lives.

Cancer Tests for Women: Provista Life Sciences offers two unique oncological tests for the early detection of cancer: the BT Test™ and the RCP Test™. The BT Test, which stands for Biomarker Translation Test, is designed to aid in the detection of breast cancer, the deadliest cancer amongst women. The test assists physicians in making an earlier and more accurate diagnosis of breast cancer when used adjunctively with a mammogram. The RCP Test, which stands for Riboflavin Carrier Protein, is a blood test that aids in the detection of several reproductive cancers including ovarian, uterine and cervical cancer.

Alzheimer's & Memory Tests: Provista Life Sciences is on the forefront of Alzheimer's disease detection with innovative, affordable tests to aid doctors and patients in recognizing the disease in its earliest stages.

The LymPro Test® is a pioneering blood test designed to work in conjunction with traditional diagnostic methods to help physicians develop a timelier, conclusive diagnosis of Alzheimer's disease.

In addition to this test, the company offers two self-administered tests; the Provista Memory Test™ for cognitive and memory impairment, and The Provista Memory Test Plus™ - the only FDA-cleared over-the-counter smell test on the market today.

Laboratory Arm: The groundbreaking tests offered by Provista Life Sciences are conducted through its Provista Diagnostics laboratory. Provista Diagnostics is a wholly owned subsidiary of Provista Life Sciences and offers services to doctors' offices, clinics and hospitals throughout the United States.

Provista Diagnostics is a Clinical Laboratory Improvement Amendments (CLIA) registered Reference Laboratory, ensuring it follows all industry best practices and regulations. In addition to conducting the tests, Provista Diagnostics conducts extensive clinical studies to ensure the accuracy of each of its tests and technologies.

Leading Early Prevention: Provista Life Sciences is making significant strides in the early detection of critical diseases facing today's population and is setting new standards in the diagnostic technologies industry. The company has completed clinical studies and made the BT Test available to women and physicians, and is in the clinical trials for its women's cancer technologies.

Additionally, Provista Life Sciences is dedicated to further research into central nervous system diseases, with a goal of improving the care and quality of life for people suffering from memory loss and cognitive impairment.